5-year follow-up after primary percutaneous coronary intervention with a paclitaxel-eluting stent versus a bare-metal stent in acute ST-segment elevation myocardial infarction

JACC: Cardiovascular Interventions

Volumn 4, Issue 1, 2011, Pages 24-29

  Vink, Maarten A ^a   Dirksen, Maurits T ^a   Suttorp, Maarten J ^c   Tijssen, Jan G P ^b   Van Etten, Jeroen ^a   Patterson, Mark S ^a   Slagboom, Ton ^a   Kiemeneij, Ferdinand ^a   Laarman, Gerrit J ^d  

^a Onze Lieve Vrouwe Gasthuis ^*  (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c ST ANTONIUS HOSPITAL   (Netherlands)

^d CPRLab   (Netherlands)

Author keywords

drug eluting stent; primary percutaneous coronary intervention; ST segment elevation myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; PACLITAXEL;

ADULT; ARTICLE; BARE METAL STENT; COMPARATIVE STUDY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART DEATH; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; REVASCULARIZATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; TREATMENT OUTCOME;

ANGIOPLASTY, BALLOON, CORONARY; CARDIOVASCULAR AGENTS; DRUG-ELUTING STENTS; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; METALS; MYOCARDIAL INFARCTION; NETHERLANDS; PACLITAXEL; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; SINGLE-BLIND METHOD; STENTS; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 78751674926     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2010.11.003     Document Type: Article

References (22)

1. C.L. Grines, D.A. Cox, and G.W. Stone Coronary angioplasty with or without stent implantation for acute myocardial infarction Stent Primary Angioplasty in Myocardial Infarction Study Group N Engl J Med 341 1999 1949 1956
2. G. De Luca, H. Suryapranata, and G.W. Stone Coronary stenting versus balloon angioplasty for acute myocardial infarction: a meta-regression analysis of randomized trials Int J Cardiol 126 2008 37 44
3. G.W. Stone, S.G. Ellis, D.A. Cox TAXUS-IV Investigators A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease N Engl J Med 350 2004 221 231
4. G.W. Stone, J.W. Moses, and S.G. Ellis Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents N Engl J Med 356 2007 998 1008
5. G.J. Laarman, M.J. Suttorp, and M.T. Dirksen Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention N Engl J Med 355 2006 1105 1113
6. C. Spaulding, P. Henry, E. Teiger TYPHOON Investigators Sirolimus-eluting versus uncoated stents in acute myocardial infarction N Engl J Med 355 2006 1093 1104
7. G.W. Stone, A.J. Lansky, S.J. Pocock HORIZONS-AMI Trial Investigators Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction N Engl J Med 360 2009 1946 1959
8. G. De Luca, G.W. Stone, and H. Suryapranata Efficacy and safety of drug-eluting stents in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials Int J Cardiol 133 2009 213 222
9. M. Pfisterer, H.P. Brunner-La Rocca, P.T. Buser BASKET-LATE Investigators Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents J Am Coll Cardiol 48 2006 2584 2591
10. J. Daemen, P. Wenaweser, and K. Tsuchida Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study Lancet 369 2007 667 678
11. F. Van de Werf, J. Bax, and A. Betriu Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology Eur Heart J 29 2008 2909 2945
12. F.G. Kushner, M. Hand, and S.C. Smith Jr. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 54 2009 2205 2241
13. N. Kukreja, Y. Onuma, H.M. Garcia-Garcia Interventional Cardiologists of the Thoraxcenter (2000 to 2005) The risk of stent thrombosis in patients with acute coronary syndromes treated with bare-metal and drug-eluting stents J Am Coll Cardiol Intv 2 2009 534 541
14. G. Leibundgut, F. Nietlispach, and U. Pittl Stent thrombosis up to 3 years after stenting for ST-segment elevation myocardial infarction versus for stable anginacomparison of the effects of drug-eluting versus bare-metal stents Am Heart J 158 2009 71 76
15. M.T. Dirksen, M.A. Vink, M.J. Suttorp PASSION Investigators Two year follow-up after primary PCI with a paclitaxel-eluting stent versus a bare-metal stent for acute ST-elevation myocardial infarction (the PASSION trial): a follow-up study EuroIntervention 4 2008 64 70
16. D.E. Cutlip, S. Windecker, R. Mehran Academic Research Consortium Clinical endpoints in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
17. M. Menichelli, A. Parma, and E. Pucci Randomized trial of sirolimus-eluting stent versus bare-metal stent in acute myocardial infarction (SESAMI) J Am Coll Cardiol 49 2007 1924 1930
18. T. Uchida, J. Popma, and G.W. Stone The clinical impact of routine angiographic follow-up in randomized trials of drug-eluting stents: a critical assessment of "oculostenotic" reintervention in patients with intermediate lesions J Am Coll Cardiol Intv 3 2010 403 411
19. R. Violini, C. Musto, and F. De Felice Maintenance of long-term clinical benefit with sirolimus-eluting stents in patients with ST-segment elevation myocardial infarction 3-year results of the SESAMI (Sirolimus-Eluting Stent versus Bare-Metal Stent in Acute Myocardial Infarction) trial J Am Coll Cardiol 55 2010 810 814
20. G. Nakazawa, A.V. Finn, and M. Joner Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study Circulation 118 2008 1138 1145
21. G.W. Stone, A. Rizvi, W. Newman SPIRIT IV Investigators Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease N Engl J Med 362 2010 1663 1674
22. E. Kedhi, K.S. Joesoef, and E. McFadden Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial Lancet 375 2010 201 209